The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Dissecting the genomic complexity underlying medulloblastoma
Open accessAbstract
Medulloblastoma is the most common brain tumour in children; using whole-genome sequencing of tumour samples the authors show that the clinically challenging Group 3 and 4 tumours can be tetraploid, and reveal the expression of the first medulloblastoma fusion genes identified. Medulloblastoma is the most common malignant brain tumour in children. Four papers published in the 2 August 2012 issue of Nature use whole-genome and other sequencing techniques to produce a detailed picture of the genetics and genomics of this condition. Notable findings include the identification of recurrent mutations in genes not previously implicated in medulloblastoma, with significant genetic differences associated with the four biologically distinct subgroups and clinical outcomes in each. Potential avenues for therapy are suggested by the identification of targetable somatic copy-number alterations, including recurrent events targeting TGFβ signalling in Group 3, and NF-κB signalling in Group 4 medulloblastomas. Medulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. It is the most common malignant brain tumour in children, and shows tremendous biological and clinical heterogeneity1. Despite recent treatment advances, approximately 40% of children experience tumour recurrence, and 30% will die from their disease. Those who survive often have a significantly reduced quality of life. Four tumour subgroups with distinct clinical, biological and genetic profiles are currently identified2,3. WNT tumours, showing activated wingless pathway signalling, carry a favourable prognosis under current treatment regimens4. SHH tumours show hedgehog pathway activation, and have an intermediate prognosis2. Group 3 and 4 tumours are molecularly less well characterized, and also present the greatest clinical challenges2,3,5. The full repertoire of genetic events driving this distinction, however, remains unclear. Here we describe an integrative deep-sequencing analysis of 125 tumour–normal pairs, conducted as part of the International Cancer Genome Consortium (ICGC) PedBrain Tumor Project. Tetraploidy was identified as a frequent early event in Group 3 and 4 tumours, and a positive correlation between patient age and mutation rate was observed. Several recurrent mutations were identified, both in known medulloblastoma-related genes (CTNNB1, PTCH1, MLL2, SMARCA4) and in genes not previously linked to this tumour (DDX3X, CTDNEP1, KDM6A, TBR1), often in subgroup-specific patterns. RNA sequencing confirmed these alterations, and revealed the expression of what are, to our knowledge, the first medulloblastoma fusion genes identified. Chromatin modifiers were frequently altered across all subgroups. These findings enhance our understanding of the genomic complexity and heterogeneity underlying medulloblastoma, and provide several potential targets for new therapeutics, especially for Group 3 and 4 patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Self-citationThe Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C. L., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,541
Self-citationMassive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Molecular subgroups of medulloblastoma: the current consensus
Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936
Self-citationMedulloblastoma Comprises Four Distinct Molecular Variants
Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S. C., Bouffet, É., Clifford, S. C., Hawkins, C. E., French, P. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4324 · Cited by 1,353
Self-citationEnglund, C., Fink, A., Lau, C., Pham, D., Daza, R. A. M., Bulfone, A., Kowalczyk, T., & Hevner, R. F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2899-04.2005 · Cited by 1,261
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C. L., Stevenson, K. E., Werner, L. L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,103
Self-citationKool, M., Korshunov, A., Remke, M., Jones, D., Schlanstein, M., Northcott, P. A., Cho, Y., Köster, J., Meeteren, A. Y. N. S., van Vuurden, D. G., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,057
Self-citationRausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Self-citation
Flagged first, then by citations
2 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 852
Comparison of clinical and molecular wnt and shh subgroups in medulloblastoma tumor cases
Kaya, I. S., Aksoy, S. A., Mutlu, M. B., Tekin, Ç., Taşkapılıoğlu, M. Ö., Tunca, B., Civan, M. N., Ocak, P. E., Kocaelı, H., Bekâr, A., et al. (2020) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.32057-20.3 · Cited by 2
Smoothened Inhibitors in Cancer
Ruat, M., & Hoch, L. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_85 · Cited by 2
Wang, D., Ma, K., Deng, W., Li, J., Xiang, S., Zhang, Y., Fu, Y., Dai, H., & Huang, B. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s299381 · Cited by 2
Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery
Mengwasser, K. E. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 2
Carrio-Cordo, P., & Baudis, M. (2021) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-220990 · Cited by 2
Owens, M. C., Shen, H., Yanas, A. M., Mendoza-Figueroa, M. S., Lavorando, E., Wei, X., Shweta, H., Tang, H., Goldman, Y. E., & Liu, K. F. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.19.533240 · Cited by 2
Cell-state plasticity drives heterogeneity in Group 3/4 medulloblastomaPreprint
Joshi, P. K., da Silva, P. B. G., Okonechnikov, K., Stelzer, T., Sarropoulos, I., Sepp, M., Nolle, J., Pour-Jamnani, M. V., Rademacher, A., Yamada-Saito, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.09.579680 · Cited by 2
Self-citationModelling medulloblastoma pathogenesis and treatment in human cerebellar organoidsPreprint
Willott, T., Nicholson, J. G., Xiao, Y., Ogunbiyi, O. K., Draper, B., Mistry, T., Donovan, L., Zabet, N. R., Merve, A., Badodi, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.14.607977 · Cited by 2
Consistently processed RNA sequencing data from 50 sources enriched for pediatric data
Beale, H. C., Learned, K., Kephart, E. T., Lyle, A. G., van den Bout, A., McCabe, M. M., Echandia-Monroe, K., Khare, M. J., Huang, E. Y., Jariwala, S., et al. (2025) · Scientific Data · doi:10.1038/s41597-025-05376-z · Cited by 2
Self-citationModeling medulloblastoma pathogenesis and treatment in human cerebellar organoidsPreprint
Willott, T., Nicholson, J. G., Zhang, X., Xiao, Y., Ogunbiyi, O. K., Draper, B., Mistry, T., Donovan, L., Merve, A., Zabet, N. R., et al. (2026) · Genes & Development · doi:10.1101/gad.353292.125 · Cited by 2
Gangwani, K., Lu, C., Dhanda, S. K., Sioson, E., Zaldívar Peraza, A., Matt, G. Y., Paul, R., Wang, J., Reilly, C., Acić, A., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4976 · Cited by 1
“…found in G3 and G4 tumors include amplifications of MYC and OTX2 , activation of GFI1B or GFI1 , mutations in KBTBD4 , enhancer hijacking of PRDM6 , mutations in KDM6A , large cell/anaplastic histology, loss of chromosome 10, presence of isochromosome 17q (iso17), and amplification of CDK6 (7–11).”
Self-citationBasic Science of Pediatric Brain Tumors
Taccone, M. S., Srikanthan, D., Rutka, J. T., & Ramaswamy, V. (2024) · Springer eBooks · doi:10.1007/978-3-031-62017-1_7 · Cited by 1
Bi, Y., Sun, J., Ren, D., Gong, X., Ji, L., Lu, P., Yuan, F., Wang, Y., Li, K., Long, L., et al. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf083 · Cited by 1
Challenges and opportunities for treatment of medulloblastoma
Mehta, M., Somasundaram, D. B., Munshi, A., & Ramesh, R. (2025) · Advances in cancer research · doi:10.1016/bs.acr.2025.06.006 · Cited by 1
Beyond Darwin: reactive heredity, burst-drift dynamics and eco‑evolutionary control of cancer
Lagache, L., Salzet, J., Fournier, I., & Salzet, M. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02683-w · Cited by 1
Inhibitors of Jumonji C-Domain Histone Demethylases
Staller, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00020-3 · Cited by 1
New Molecular Targets and Treatments for Pediatric Brain Tumors
Cacciari, C., Kayath, C. A., & James, T. (2013) · InTech eBooks · doi:10.5772/53300 · Cited by 1
Holland, H., Xu, L., Ahnert, P., Kirsten, H., Koschny, R., Bauer, M., Schober, R., Meixensberger, J., & Krupp, W. (2013) · Pathology - Research and Practice · doi:10.1016/j.prp.2013.06.001 · Cited by 1
Jäger, N., Jones, D., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y., Pugh, T. J., Hovestadt, V., Stütz, A. M., et al. (2012) · BMC Proceedings · doi:10.1186/1753-6561-6-s6-p43 · Cited by 1
Self-citationTumor Prognostic Factors and the Challenge of Developing Predictive Factors
Holliday, E. B., & Sulman, E. P. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0283-3 · Cited by 1
The Genome of Polymorphonuclear Neutrophils Maintains Normal Coding Sequences
Xiao, F., Kim, Y. C., Wen, H., Luo, J., Chen, P., Cowan, K. H., & Wang, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078685 · Cited by 1
Self-citationYahav, G., Fixler, D., Gershanov, S., & Goldenberg‐Cohen, N. (2016) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2208014 · Cited by 1
Update zur personalisierten Diagnostik und Behandlung krebskranker Kinder
Eggert, A. (2013) · Klinische Pädiatrie · doi:10.1055/s-0033-1347183 · Cited by 1
Standardized Molecular and Genetic Diagnosis of Medulloblastoma
Kanemura, Y., Ichimura, K., Shofuda, T., Yamasaki, M., Shibui, S., Arai, H., & Nishikawa, R. (2015) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.24.436 · Cited by 1
Liang, L., Aiken, C., Felton, K. E. A., Hogg, A., van Landeghem, F. K. H., Klonisch, T. C., Eisenstat, D. D., & Werbowetski‐Ogilvie, T. E. (2017) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-59749-2_16 · Cited by 1
Kuzan-Fischer, C. M., Ferry, I., Stücklin, A. G., & Taylor, M. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_28 · Cited by 1
Self-citationPediatric CNS cancer genomics and immunogenomics
Miller, K. E., & Mardis, E. R. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101918 · Cited by 2
Liang, L., Borlase, S., Aiken, C., Felton, K. E. A., Hogg, A., van Landeghem, F. K. H., Klonisch, T. C., Eisenstat, D. D., & Werbowetski‐Ogilvie, T. E. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-23104-9_19 · Cited by 1
MOADE: a multimodal autoencoder for dissociating bulk multi-omics data
Sun, J., Malik, A. A., Lin, T., Bratton, A., Pan, Y., Smith, K. S., Onar‐Thomas, A., Robinson, G. W., Zhang, W., Northcott, P. A., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03805-1 · Cited by 1
Self-citationBasic Science of Pediatric Brain Tumors
Mack, S. C., Ramaswamy, V., Wang, X., Remke, M., Sin‐Chan, P., Chan, T. S. Y., Bertrand, K. C., Merino, D. M., Zayne, K., Huang, A., et al. (2015) · Springer eBooks · doi:10.1007/978-1-4939-1541-5_7 · Cited by 1
Self-citationDDX3-mediated translational activation drives β-catenin signaling and cancer cell motility
(2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.392 · Cited by 1
Medulloblastoma: Clinical Challenges and Emerging Molecular Discoveries
Trieu, E., Huang, S., & Yang, J. (2016) · InTech eBooks · doi:10.5772/63004 · Cited by 1
Sankar, S., Patterson, E., Lewis, E. M. A., Waller, L. E., Tong, C., Dearborn, J. T., Wozniak, D. F., Rubin, J. B., & Kroll, K. L. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.157 · Cited by 1
DISORDERED HISTONE METHYLATION IN HEMATOLOGICAL MALIGNANCIES THE CASE OF UTX/KDM6A.
Licht, J. D. (2018) · Europe PMC (PubMed Central) · Cited by 2
Drug Re-Purposing - Can Anti-Allergy Drugs also be Used to Treat Cancer?
Moschou, G., & Topham, C. H. (2020) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2020.03.0634
Update in Pediatric Neuro-Oncology
Khatua, S., & Pillay Smiley, N. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-540-3 · Cited by 1
RNA Helicases and Their Cofactors
Shahbazian, D., Pelletier, J., Svitkin, Y. V., Hershey, J. W. B., & Parsyan, A. E. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_5 · Cited by 1
Identification of novel tumor predisposition families and underlying genetic defects
Aavikko, M. (2014) · Työväentutkimus Vuosikirja · Cited by 1
Integrating NGS and third-generation sequencing technologies into clinical genomic medicine
Tzaphlidou, M., Papaloukas, C. L., & Roukos, D. H. (2013) · doi:10.2217/ebo.12.341 · Cited by 1
Guiding Cancer Therapy: Evidence-driven Reporting of Genomic Data
Perera‐Bel, J. (2018) · doi:10.53846/goediss-7161 · Cited by 1
*K-means and Cluster Models for Cancer SignaturesPreprint
Kakushadze, Z., & Yu, W. (2017) · RePEc: Research Papers in Economics · doi:10.48550/arxiv.1703.00703 · Cited by 1
Shimada, I. S., Hwang, S., Somatilaka, B. N., Wang, X., Skowron, P., Kim, J., Kim, M., Shelton, J. M., Rajaram, V., Xuan, Z., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155780 · Cited by 1
Self-citationMountains and Chasms - Surveying the Oncogenomic Publication LandscapePreprint
Carrio-Cordo, P., & Baudis, M. (2018) · Preprints.org · doi:10.20944/preprints201807.0618.v1 · Cited by 1
DDX3X Loss is Associated with Aggressive Phenotypes in Non-Hodgkin’s LymphomasPreprint
Kizhakeyil, A., Zaini, N. B. M., Poh, Z. S., Wong, B. H. S., Loh, X., Ng, A. S., Low, Z. S., Prasannan, P., Gong, J., Tan, M. G. K., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-209388/v1 · Cited by 1
Carrio-Cordo, P., & Baudis, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.01.433348 · Cited by 1
Horak, P., Heining, C., Kreutzfeldt, S., Hutter, B., Möck, A., Hüllein, J., Fröhlich, M., Uhrig, S., Jahn, A., Rump, A., et al. (2023) · doi:10.1158/2159-8290.22540591 · Cited by 1
Self-citationShi, X., & Wu, J. I. (2013) · Defense Technical Information Center (DTIC) · doi:10.21236/ada599190
Discovery of Synthetic Lethal Interactions with CDH1 in Medulloblastoma
Brew, T. P. (2015) · Otago University Research Archive (University of Otago)
Immune Molecules Regulate Medulloblastoma and Neuronal Apoptosis
Knight, E. R. W. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/cqj0-1729
Genomic Characterization of Meningiomas
Horowitz, P. M., Beroukhim, R., Dunn, I. F., & Brastianos, P. K. (2013)
Xiong, A. (2015) · Uppsala University Publications (Uppsala University)
Targeted Therapies for Pediatric Solid Tumors
Dao, J. Q., & Zweidler‐McKay, P. A. (2015) · doi:10.1002/9781118468678.ch27
Medulloblastomas: Survival Differences Between Children and Adults
Smoll, N. R. (2013) · Tumors of the central nervous system · doi:10.1007/978-94-007-7217-5_10
Wortham, M. (2012) · DukeSpace (Duke University)
REGULATION OF THE OXIDATIVE STRESS RESPONSE BY ARID1A
Kwan, S. Y. (2015) · Digital Commons-TMC (Texas Medical Center)
Comparative Oncogenomics for Peripheral Nerve Sheath Cancer Gene Discovery
Carroll, S. L. (2015) · Defense Technical Information Center (DTIC) · doi:10.21236/ada624248
The Role of SOX9 in Medulloblastoma
Savov, V. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
The Role of Platelet-Derived Growth Factor Receptor Signaling in Medulloblastoma Metastasis
Bhat, K. (2013) · NDSU Repository (North Dakota State University)
Polo-like kinase 1 as a prognostic and therapeutic target in high-grade brain tumors
Triscott, J. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0166568
Werbowetski‐Ogilvie, T. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800781-5.00018-9
The Epigenetics of Medulloblastoma
Penas, C., Stathias, V., Allen, B. K., & Ayad, N. G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00014-8
Role of Next-Generation Sequencing Technologies
Devarakonda, S. H. K., Morgensztern, D., & Govindan, R. (2013) · CRC Press eBooks · doi:10.1201/b15944-2
Genomic Landscape of Brain Tumors
Clark, V. E., Youngblood, M. W., Bai, H., Günel, J. M., & Günel, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00040-8
Stem Cell Signaling in the Heterogeneous Development of Medulloblastoma
Triscott, J., & Dunn, S. E. (2016) · Wiley eBooks · doi:10.1002/9781119135449.ch21
Characterization of the Myc-JPO2 Transformation Axis in Medulloblastoma
Chan, T. S. Y. (2015) · TSpace (University of Toronto)
INVESTIGATING THE ROLE OF DEAD-BOX HELICASE DDX3 MUTATIONS IN MEDULLOBLASTOMA
Whelan, A. B., & WHELAN, A. B. (2016) · UA Campus Repository (The University of Arizona)
Atypical and Malignant Meningiomas
Castro, B. A., Chua, M. M. J., & Brastianos, P. K. (2017) · doi:10.1002/9781119196235.ch59
Internationales Krebsgenomkonsortium (ICGC)
Siebert, R., Gerhäuser, C., Simon, R., Wagener, R., Weber, U. D., Sauter, G., Plass, C., & Lichter, P. (2016) · Medizinische Genetik · doi:10.1007/s11825-017-0117-7
Self-citationFator de pluripotência OCT4A e agressividade de meduloblastoma humano
da Silva, P. B. G. (2017) · doi:10.11606/t.41.2017.tde-20032017-161403
Role of Patched-1 Intracellular Domains in Canonical and Non-Canonical Hedgehog Signalling Events
Harvey, M. C. (2013) · TSpace (University of Toronto)
Ke, C., Wang, J., Xi, S., Li, K. K., Luo, J., Chen, Z., Wang, J., & Chen, Z.-P. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.08.094
Kim, Y. Z. (2017) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100083
Self-citationChemical and CRISPR/Cas9 Tools for Functional Characterization of RNA Helicases
Chu, J., & Pelletier, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-8372-3_14
Onkologische Grundlagen und Molekulargenetik von ZNS-Tumoren im Kindes- und Jugendalter
Sturm, D., Pfister, S. M., & Witt, H. (2018) · Springer eBooks · doi:10.1007/978-3-662-48700-6_32
Self-citationIntegrated Genomic and Epigenomic Analyses of Atypical Teratoid Rhabdoid Tumour
Torchia, J. (2016) · TSpace (University of Toronto)
Neuropsychiatry: Aspects of Childhood Cranial Tumours
Hegarty, A., & Furlong, Y. (2018) · InTech eBooks · doi:10.5772/intechopen.75679
Estudo da expressão dos genes TETs e níveis de hidroximetilação em meduloblastoma
Salomão, K. B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-18042018-104554
Modern Principles of CNS Tumor Classification
Pfister, S. M., Capper, D., & Jones, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-43205-2_6
Self-citationA Tumor-derived Niche Cell Promotes Tumor Growth in Medulloblastoma
Ventura, P. B. (2015) · doi:10.18130/v3754q
Unmasking Novel Epigenetic Mechanisms of Medulloblastoma Pathogenesis
Wang, X. (2016) · TSpace (University of Toronto)
Murakami, M. A. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Canonical Wnt Mechanisms in Neural Crest Induction
Perfetto, M. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7393
Targeting pro-tumorigenic signaling pathways in hematolymphoid malignancies
Kizhakeyil, A. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/142248
Meduloblastoma pediatrikoaren pronostikorako markatzaile molekularren identifikazioa
Frutos-Gallastegui, B., López-López, E., Illarregi, U., Bilbao‐Aldaiturriaga, N., García-Ariza, M., Gutiérrez-Camino, Á., & Martín‐Guerrero, I. (2021) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.21686
Kindliche Hirntumoren bei Erwachsenen: Medulloblastom
Hau, P., Schackert, G., Seidel, C., Wick, W., & Weller, M. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-46764-0_381-1
Jain, K. K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9245-0_3
A Novel Oncogenic Function of PRC2 Heterogeneity in MedulloblastomaPreprint
Yi, J., Shi, X., Zhan, X., Lu, R. Q., Xuan, Z., & Wu, J. I. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.02.470979
Genomic Applications in Brain Tumors
Snuderl, M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0727-4_21
The Genomic Landscape of Pediatric Renal Cell CarcinomasPreprint
Beck, P., Selle, B., Madenach, L., Jones, D., Vokuhl, C., Gopisetty, A., Nabbi, A., Brecht, I. B., Ebinger, M., Wegert, J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3974118
Self-citationGottardo, N. G., & Howell, C. I. (2018) · Springer eBooks · doi:10.1007/978-3-319-43205-2_7
Jain, K. K. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-272-8_18
D’Angiolella, V. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736250307.793563274
(2013) · Brain Pathology · doi:10.1111/bpa.12030
Cleton-Jansen, A. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718006007.793475858
Lin, C. Y. (2015) · Defense Technical Information Center (DTIC) · doi:10.21236/ada620612
Metadata
- Authors
- Jones, D. T. W., Jäger, N., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y.-J., Pugh, T. J., Hovestadt, V., Stütz, A. M., Rausch, T., Warnatz, H.-J., Ryzhova, M., Bender, S., Sturm, D., Pleier, S., Cin, H., Pfaff, E., Sieber, L., Wittmann, A., Remke, M., Witt, H., Hutter, S., Tzaridis, T., Weischenfeldt, J., Raeder, B., Avci, M., Amstislavskiy, V., Zapatka, M., Weber, U. D., Wang, Q., Lasitschka, B., Bartholomae, C. C., Schmidt, M., von Kalle, C., Ast, V., Lawerenz, C., Eils, J., Kabbe, R., Benes, V., van Sluis, P., Koster, J., Volckmann, R., Shih, D., Betts, M. J., Russell, R. B., Coco, S., Paolo Tonini, G., Schüller, U., Hans, V., Graf, N., Kim, Y.-J., Monoranu, C., Roggendorf, W., Unterberg, A., Herold-Mende, C., Milde, T., Kulozik, A. E., von Deimling, A., Witt, O., Maass, E., Rössler, J., Ebinger, M., Schuhmann, M. U., Frühwald, M. C., Hasselblatt, M., Jabado, N., Rutkowski, S., von Bueren, A. O., Williamson, D., Clifford, S. C., McCabe, M. G., Peter Collins, V., Wolf, S., Wiemann, S., Lehrach, H., Brors, B., Scheurlen, W., Felsberg, J., Reifenberger, G., Northcott, P. A., Taylor, M. D., Meyerson, M., Pomeroy, S. L., Yaspo, M.-L., Korbel, J. O., Korshunov, A., Eils, R., Pfister, S. M., & Lichter, P.
- Affiliations
- German Cancer Research Center (DE)
- European Molecular Biology Laboratory (DE)
- Max Planck Institute for Molecular Genetics (DE)
- Stanford University (US)
- Broad Institute (US)
- Burdenko Neurosurgery Institute (RU)
- Amsterdam UMC Location University of Amsterdam (NL)
- Hospital for Sick Children (CA)
- Heidelberg University (DE)
- Ospedale Policlinico San Martino (IT)
- Institut für Neuropathologie (DE)
- Evangelisches Krankenhaus Bielefeld (DE)
- Universitätsklinikum des Saarlandes (DE)
- University of Würzburg (DE)
- University Hospital Heidelberg (DE)
- Olgahospital (DE)
- University Medical Center Freiburg (DE)
- University Children's Hospital Tübingen (DE)
- University Hospital Münster (DE)
- McGill University Health Centre (CA)
- University Medical Center Hamburg-Eppendorf (DE)
- Royal Victoria Infirmary (GB)
- University of Cambridge (GB)
- Cnopf´sche Kinderklinik (DE)
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Eils, Roland
- Pfister, Stefan M.
- Lichter, Peter
- ORCID
- Jones, David T. W.
- Jäger, Natalie
- Kool, Marcel
- Zichner, Thomas
- Hutter, Barbara
- Sultan, Marc
- Cho, Yoon-Jae
- Pugh, Trevor J.
- Hovestadt, Volker
- Stütz, Adrian M.
- Rausch, Tobias
- Warnatz, Hans-Jörg
- Ryzhova, Marina
- Sturm, Dominik
- Pfaff, Elke
- Remke, Marc
- Witt, Hendrik
- Hutter, Sonja
- Tzaridis, Theophilos
- Weischenfeldt, Joachim
- Raeder, Benjamin
- Amstislavskiy, Vyacheslav
- Zapatka, Marc
- Wang, Qi
- Schmidt, Manfred
- Ast, Volker
- Kabbe, Rolf
- Volckmann, Richard
- Shih, David
- Betts, Matthew J.
- Russell, Robert B.
- Coco, Simona
- Schüller, Ulrich
- Graf, Norbert
- Kim, Yoo-Jin
- Unterberg, Andreas
- Milde, Till
- Kulozik, Andreas E.
- Witt, Olaf
- Rössler, Jochen
- Ebinger, Martin
- Schuhmann, Martin U.
- Frühwald, Michael C.
- Hasselblatt, Martin
- Jabado, Nada
- Rutkowski, Stefan
- Clifford, Steven C.
- McCabe, Martin G.
- Wiemann, Stefan
- Brors, Benedikt
- Felsberg, Jörg
- Reifenberger, Guido
- Northcott, Paul A.
- Taylor, Michael D.
- Meyerson, Matthew
- Pomeroy, Scott L.
- Yaspo, Marie-Laure
- Korbel, Jan O.
- Korshunov, Andrey
- Eils, Roland
- Pfister, Stefan M.
- Lichter, Peter
- Venue
- Nature
- Published
- 2012-07-25
- Volume
- 488
- Issue
- 7409
- Pages
- 100-105
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3662966
- OpenAlex
- W2167532631
- Cited by
- 839
- References
- 27
- Citations by year
- 2026: 8 · 2025: 31 · 2024: 28 · 2023: 41 · 2022: 42 · 2021: 60 · 2020: 51 · 2019: 49 · 2018: 69 · 2017: 73 · 2016: 86 · 2015: 81 · 2014: 89 · 2013: 102 · 2012: 28
- FWCI
- 45.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by-nc-sa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Pediatric Brain Tumor Foundation
- Deutsches Krebsforschungszentrum
- Children's Cancer and Leukaemia Group
- Cancer Research UK (13457)
- Brain Tumour Charity (16/92, 10/106)
- Bundesministerium für Bildung und Forschung (01GS0883)
- Hungarian Scientific Research Fund
- Max-Planck-Gesellschaft
- Deutsche Krebshilfe (109252)
- Heidelberger Zentrum für Personalisierte Onkologie Deutsches Krebsforschungszentrum In Der Helmholtz-Gemeinschaft
- National Cancer Institute (R01CA109467)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- medulloblastoma, Group 3 medulloblastoma, Group 4 medulloblastoma, tetraploidy, somatic copy number alterations, TGF-beta signaling, NF-κB signaling, recurrent mutations, pediatric brain tumors, tumor heterogeneity
- MeSH terms
- Patched Receptors, Patched-1 Receptor, Aging, Amino Acid Sequence, Cell Transformation, Neoplastic, Cerebellar Neoplasms, Child, Chromatin, Chromosomes, Human, DNA Helicases, DNA-Binding Proteins, Humans, Medulloblastoma, Methylation, Mutation, Neoplasm Proteins, Nuclear Proteins, Phosphoprotein Phosphatases, Polyploidy, Receptors, Cell Surface, Transcription Factors, Signal Transduction, Oncogene Proteins, Fusion, Genome, Human, Sequence Analysis, RNA, T-Box Domain Proteins, Genomics, Wnt Proteins, beta Catenin, DEAD-box RNA Helicases, Hedgehog Proteins, Histone Demethylases, High-Throughput Nucleotide Sequencing, Mutation Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
